| Literature DB >> 23201691 |
Yuta Fujiwara1, Janice A Dixon, Fionn O'Hara, Erik Daa Funder, Darryl D Dixon, Rodrigo A Rodriguez, Ryan D Baxter, Bart Herlé, Neal Sach, Michael R Collins, Yoshihiro Ishihara, Phil S Baran.
Abstract
Nitrogen-rich heterocyclic compounds have had a profound effect on human health because these chemical motifs are found in a large number of drugs used to combat a broad range of diseases and pathophysiological conditions. Advances in transition-metal-mediated cross-coupling have simplified the synthesis of such molecules; however, C-H functionalization of medicinally important heterocycles that does not rely on pre-functionalized starting materials is an underdeveloped area. Unfortunately, the innate properties of heterocycles that make them so desirable for biological applications--such as aqueous solubility and their ability to act as ligands--render them challenging substrates for direct chemical functionalization. Here we report that zinc sulphinate salts can be used to transfer alkyl radicals to heterocycles, allowing for the mild (moderate temperature, 50 °C or less), direct and operationally simple formation of medicinally relevant C-C bonds while reacting in a complementary fashion to other innate C-H functionalization methods (Minisci, borono-Minisci, electrophilic aromatic substitution, transition-metal-mediated C-H insertion and C-H deprotonation). We prepared a toolkit of these reagents and studied their reactivity across a wide range of heterocycles (natural products, drugs and building blocks) without recourse to protecting-group chemistry. The reagents can even be used in tandem fashion in a single pot in the presence of water and air.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23201691 PMCID: PMC3518649 DOI: 10.1038/nature11680
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962
Figure 1Development of a reagent toolkit for an innate C–H functionalization of heterocycles
A modular set of zinc sulfinate salts were identified as being highly desirable for the installation of medicinally relevant moieties (Fig. 1C): zinc trifluoromethanesulfinate (TFMS; A), zinc difluoromethanesulfinate (DFMS; B), zinc trifluoroethanesulfinate (TFES; C), zinc monofluoromethanesulfinate (MFMS; D), zinc isopropylsulfinate (IPS; E), and zinc triethyleneglycolsulfinate (TEGS; F). The fluoroalkyl and alkyl groups that we wish to introduce hold privileged positions in drug discovery and are described in detail below.
Substrate scope of the zinc sulfinate salt toolkit
Isolated yields are displayed, % conversions by GC-MS are indicated between parentheses, and regioisomeric ratios are shown between square brackets. Compounds 1A, 2A, 3A, 4A and 5A have been previously synthesized with Langlois’ reagent (ref. 7); 1B, 2B, 3B, 4B, 5B and 8B have been previously prepared using DFMS (ref. 9) and are included herein for completeness; all other compounds in this table are new.
|
| ||||||
|---|---|---|---|---|---|---|
|
| ||||||
| Zn salt; R =
| CF3 (A) | CF2H (B) | CF2CF3 (C) | CF2F (D) | CH(CH3)2 (E) | (CH2CH2O)3CH3 (F) |
| heterocycle | ||||||
|
| ||||||
| 1 | 89 (100) | 73 (57) | 51 | 80 | 41 | 40 |
| 1A | 1B | 1C | 1D | 1E | 1F | |
|
| ||||||
| 2 | 79 (100) | 72 (41) | 44 | 75 | 37 | 49 |
| 2A | 2B | 2C | 2D | 2E | 2F | |
|
| ||||||
| 3 | 35 (77) | 66 (100) | 18 (85) | 73 | 47 | 41 |
| 3A | 3B | 3C | 3D | 3E | 3F | |
|
| ||||||
| 4 | 66 (65) | 60 (96) | 33 | N.R. | 41 | N.R. |
| 4A | 4B | 4C | 4D | 4E | 4F | |
|
| ||||||
| 5 | 75 (100) | 50 (67) | 31 (77) | 56 | 43 | 32 |
| 5A | 5B | 5C | 5D | 5E | 5F | |
|
| ||||||
| 6 | 42 (44) | 21 (44) | 21 | N.R. | 46 | 16 |
| 6A | 6B | 6C | 6D | 6E | 6F | |
|
| ||||||
| 7 | 45 (90) | 57 (71) | N.R. | N.R. | 49 | 32 (38) |
| 7A | 7B | 7C | 7D | 7E | 7F | |
|
| ||||||
| 8 | 76 (91) | 65 (100) | 58 | 40 | 17 | 10 (43) |
| 8A | 8B | 8C | 8D | 8E | 8F | |
Standard conditions involve heterocycle (1.0 equiv), zinc salt (2.0–3.0 equiv), TBHP (3.0–5.0 equiv) and solvent:H2O (2.5:1) at a specified temperature for a period of 3–12 h. Solvent/temperature:
CH2Cl2, RT;
ClCH2CH2Cl, RT;
ClCH2CH2Cl, 50 °C;
perfluorohexane, RT;
perfluorotoluene, RT;
perfluorotoluene, 50 °C;
DMSO, 50 °C;
anisole, 50 °C (note: the reaction time for anisole is 0.5–96 h, see Supplementary Information).
TFA was used as an additive.
When the GC % conversion is lower than the isolated yield, it signifies that only one addition of Zn salt was made for the “GC yield reaction”, but that a second addition of Zn salt and TBHP was performed after 12 h for the “isolated yield reaction”.
TBHP = tert-butyl hydroperoxide; TFA = trifluoroacetic acid; RT = room temperature; N.R. = no reaction.
Figure 2Chemoselectivity, rapid diversity and complexity generation, and practical utility
Cy = cyclohexyl. a % conversion as observed by GC-MS analysis. b 6% yield of the C5-cyclohexyl isomer was also obtained.